These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A reliable and simple method for simultaneous determination of DOPA and 3-O-methyldopa in plasma and brain. Fahn S; Prasad AL; Delesie R Anal Biochem; 1972 Apr; 46(2):557-75. PubMed ID: 4337048 [No Abstract] [Full Text] [Related]
3. L-dopa therapy in parkinsonism: mechanism of action. Sandler M Psychiatr Neurol Neurochir; 1971; 74(4):331-3. PubMed ID: 5146239 [No Abstract] [Full Text] [Related]
4. A method for the determination of dopa and 3-O-methyldopa in the plasma of Parkinsonian patients. Curzon G; Kantamaneni BD; Trigwell J Clin Chim Acta; 1972 Mar; 37():335-41. PubMed ID: 5022098 [No Abstract] [Full Text] [Related]
5. 3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease. Muenter MD; Dinapoli RP; Sharpless NS; Tyce GM Mayo Clin Proc; 1973 Mar; 48(3):173-83. PubMed ID: 4570387 [No Abstract] [Full Text] [Related]
6. Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486). Yahr MD; Duvoisin RC; Mendoza MR; Schear MJ; Barrett RE Trans Am Neurol Assoc; 1971; 96():55-8. PubMed ID: 5159129 [No Abstract] [Full Text] [Related]
7. 3-methoxy-4-hydroxyphenylalanine (3-O-methyldopa) in plasma during oral L-dopa therapy of patients with Parkinson's disease. Sharpless NS; Muenter MD; Tyce GM; Owen CA Clin Chim Acta; 1972 Mar; 37():359-69. PubMed ID: 5022100 [No Abstract] [Full Text] [Related]
8. Synergism of levodopa by alpha methyldopa. Fermaglich J; O'Doherty DS Trans Am Neurol Assoc; 1971; 96():231-4. PubMed ID: 5159089 [No Abstract] [Full Text] [Related]
9. The metabolism of L-3-O-methyldopa, a precursor of dopa in man. Kuruma I; Bartholini G; Tissot R; Pletscher A Clin Pharmacol Ther; 1971; 12(4):678-82. PubMed ID: 5567811 [No Abstract] [Full Text] [Related]
10. Plasma 3-0-methyldopa in L-dopa therapy of Parkinson's disease. Muenter MD; Sharpless NS; Tyce GM Mayo Clin Proc; 1972 Jun; 47(6):389-95. PubMed ID: 5041685 [No Abstract] [Full Text] [Related]
11. Interaction between levodopa and methyldopa. Gibberd FB; Small E Br Med J; 1973 Apr; 2(5858):90-1. PubMed ID: 4573316 [TBL] [Abstract][Full Text] [Related]
12. Action of L- -methyldopa-hydrazine on the blood pressure of patients receiving levodopa. Calne DB; Petrie A; Rao S; Reid JL; Vakil SD Br J Pharmacol; 1972 Jan; 44(1):162-4. PubMed ID: 5015036 [TBL] [Abstract][Full Text] [Related]
13. A therapeutic paradox? Combined treatment of Parkinson's disease with levodopa and methyldopa. Kofman OS Arch Neurol; 1973 Aug; 29(2):120-1. PubMed ID: 4717719 [No Abstract] [Full Text] [Related]
14. Levodopa and pressor amine sensitivity in parkinsonism. Reid JL; Calne DB; George CF; Vakil SD Clin Pharmacol Ther; 1972; 13(3):400-6. PubMed ID: 5026378 [No Abstract] [Full Text] [Related]
15. Methyldopa as an adjunct to levodopa treatment of Parkinson's disease. Sweet RD; Lee JE; McDowell FH Clin Pharmacol Ther; 1972; 13(1):23-7. PubMed ID: 5008190 [No Abstract] [Full Text] [Related]
16. Alpha-methyldopa as an adjunct to levodopa treatment of Parkinson's disease. Sweet RD; Lee JE; McDowell F Trans Am Neurol Assoc; 1971; 96():59-65. PubMed ID: 5159130 [No Abstract] [Full Text] [Related]
17. [Methyldopa and levodopa]. Chang CP Zhonghua Yi Xue Za Zhi; 1974; 7():439-41. PubMed ID: 4211508 [No Abstract] [Full Text] [Related]
18. [Dopa metabolism in relation to the therapy of Parkinson's syndrome]. Pletscher A; Bartholini G Actual Pharmacol (Paris); 1971; 24():27-49. PubMed ID: 5150621 [No Abstract] [Full Text] [Related]